All In Biotech

Drug Trial Radar · NCT05711940

Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression

Last checked: Nov 19, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 572 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

572

Actual

Start

Feb 14, 2023

Primary completion

Nov 13, 2025

Study completion Dec 2026

Sponsor

Lead sponsor
COMPASS PathwaysIndustry
Sponsor type
Industry
First posted
Feb 3, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)

Conditions

  • Treatment Resistant Depression

Interventions

  • PsilocybinDrug

    COMP360 Psilocybin administered under supportive conditions

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. COMP360 25 mg versus COMP360 1 mg for the change from baseline in MADRS total score.Time frame: Week 6

Locations

116 sites in 12 countries. Site status is shown where the registry gives one.

  • Lighthouse Psychiatry Scottsdale

    Gilbert, Arizona

  • Clinical Innovations, Inc.

    Bellflower, California

  • M3 Wake Research

    Encino, California

  • The Regents of the University of California - San Diego

    La Jolla, California

  • Kadima Neuropsychiatry Institute

    La Jolla, California

  • CalNeuro Research Group, Inc

    Los Angeles, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Piedmont Hospital Neuroscience Centre

    Oakland, California

  • ATP Clinical Research, Inc.

    Orange, California

  • CITrials

    Riverside, California

  • Lumos Clinical Research Center

    San Jose, California

  • Syrentis Clinical Research

    Santa Ana, California

  • Stanford University

    Stanford, California

  • ASCLEPES Research Centers

    Thousand Oaks, California

  • Pacific Clinical Research Management Group, LLC

    Upland, California

  • Innovative Clinical Research, Inc.

    Lauderhill, Florida

  • Central Miami Medical Institute, LLC

    Miami, Florida

  • Behavioral Clinical Research, Inc.

    Miami Lakes, Florida

  • Health Synergy Clinical Research

    Okeechobee, Florida

  • Clinical Neurosciecne Solutions, Inc. dba CNS Healthcare

    Orlando, Florida

  • APG Research, LLC- Advanced Psychiatric Group

    Orlando, Florida

  • University South Florida

    Tampa, Florida

  • Stedman Clinical Trials

    Tampa, Florida

  • Health Synergy Clinical Research, LLC

    West Palm Beach, Florida

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • iResearch Atlanta

    Decatur, Georgia

  • Rush University Medical Center

    Chicago, Illinois

  • Uptown Research Institute, LLC

    Chicago, Illinois

  • Psychiatric Medicine Associates

    Skokie, Illinois

  • Harvard Medical School - McLean Hospital

    Belmont, Massachusetts

  • Adams Clinical - Boston (Copley Clinical)

    Boston, Massachusetts

  • University of Massachusetts Medical School

    North Worcester, Massachusetts

  • Adams Clinical - Boston

    Watertown, Massachusetts

  • Michigan Clinical Research Institute PC

    Ann Arbor, Michigan

  • University Of Michigan Comprehensive Depression Center

    Ann Arbor, Michigan

  • Institute for Integrative Therapies

    Eden Prairie, Minnesota

  • St. Charles Psychiatric Associates - Midwest Research Group

    Saint Charles, Missouri

  • Alivation Research, LLC.

    Lincoln, Nebraska

  • Hassman Research Institute

    Berlin, New Jersey

  • Princeton Medical Institute

    Princeton, New Jersey

Showing 40 of 116 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.